Resolutions from Novozymes A/S’ Extraordinary Shareholders’ Meeting on 30 March 2023

Staff March 30, 2023

Please read the announcement in PDF

Attachment

More Stories

Hankyung.com introduces: MecKare, Leading the AI-powered Innovation in Health Monitoring Solution

Staff November 23, 2024

Attruby™ (acoramidis), a Near Complete TTR Stabilizer (≥90%), approved by FDA to Reduce Cardiovascular Death and Cardiovascular-related Hospitalization in ATTR-CM Patients

Staff November 23, 2024

Redefining the Standard of Care: Introducing the Aulisa® Monitor Camera for Advanced Patient Monitoring

Staff November 23, 2024

You may have missed

Hankyung.com introduces: MecKare, Leading the AI-powered Innovation in Health Monitoring Solution

Staff November 23, 2024

Attruby™ (acoramidis), a Near Complete TTR Stabilizer (≥90%), approved by FDA to Reduce Cardiovascular Death and Cardiovascular-related Hospitalization in ATTR-CM Patients

Staff November 23, 2024

Redefining the Standard of Care: Introducing the Aulisa® Monitor Camera for Advanced Patient Monitoring

Staff November 23, 2024

Fitness App Market to Expand by USD 55.86 Billion (2024-2028), Driven by Health Management and Rising Chronic Disease Cases, AI Impacting Market Trends – Technavio

Staff November 23, 2024

Defence Announces Closing of Securities for Debenture Financing

Staff November 22, 2024